Restenosis and therapy

International Journal of Vascular Medicine

Volumn 2012, Issue , 2012, Pages

  Denes, Laszlo ^a   Entz, Laszlo ^a   Jancsik, Veronika ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMPHOTERICIN B; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; CYCLOSPORIN; DOXORUBICIN; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROMYCIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; IROXANADINE; LIPOPLEX; MANNOSE BINDING LECTIN 2; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C INHIBITOR; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; SHIKONIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; APOPTOSIS; ARTERIAL WALL THICKNESS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME SYNTHESIS; FOLLOW UP; GENE THERAPY; GENETICS; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; NEOINTIMA; NONHUMAN; PHENOTYPE; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; RESTENOSIS; REVIEW; RISK FACTOR; SHEAR STRESS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STENT THROMBOSIS; SURVIVAL RATE; THROMBOEMBOLISM; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM;

EID: 84866145890     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2012/406236     Document Type: Review

References (88)

1. Mack M. J., Brown P. P., Kugelmass A. D., Battaglia S. L., Tarkington L. G., Simon A. W., Culler S. D., Becker E. R., Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Annals of Thoracic Surgery 2004 77 3 761 768 2-s2.0-1442349191 10.1016/j.athoracsur.2003.06.019 (Pubitemid 38271031)
2. Curcio A., Torella D., Indolfi C., indolfi@unicz.it Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting. Circulation Journal 2011 75 6 1287 1296 10.1253/circj.CJ-11-0366
3. Szabo A., Brazda E., Dosa E., Apor A., Szabolcs Z., Entz L., Long-term restenosis rate of eversion endarterectomy on the internal carotid artery. European Journal of Vascular and Endovascular Surgery 2004 27 5 537 539 2-s2.0-1942531565 10.1016/j.ejvs.2004.02.017 (Pubitemid 38529068)
4. Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P., Belardi J., Sigwart U., Colombo A., Goy J. J., Van Den Heuvel P., Delcan J., Morel M. A., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. New England Journal of Medicine 1994 331 8 489 495 10.1056/NEJM199408253310801 (Pubitemid 24256751)
5. Kasaoka S., Tobis J. M., Akiyama T., Reimers B., Di Mario C., Wong N. D., Colombo A., Angiographic and intravascular ultrasound predictors of in-stent restenosis. Journal of the American College of Cardiology 1998 32 6 1630 1635 2-s2.0-0032533218 10.1016/S0735-1097(98)00404-5 (Pubitemid 28545201)
6. Kastrati A., Schömig A., Elezi S., Schühlen H., Wilhelm M., Dirschinger J., Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation 1998 97 24 2396 2401 2-s2.0-0032560648 (Pubitemid 28278182)
7. Elezi S., Kastrati A., Neumann F. J., Hadamitzky M., Dirschinger J., Schömig A., Vessel size and long-term outcome after coronary stent placement. Circulation 1998 98 18 1875 1880 2-s2.0-0032480806 (Pubitemid 28509283)
8. Akiyama T., Moussa I., Reimers B., Ferraro M., Kobayashi Y., Blengino S., Di Francesco L., Finci L., Di Mario C., Colombo A., Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. Journal of the American College of Cardiology 1998 32 6 1610 1618 2-s2.0-0032533254 10.1016/S0735-1097(98)00444-6 (Pubitemid 28545198)
9. Indolfi C., Pavia M., Angelillo I. F., Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). American Journal of Cardiology 2005 95 10 1146 1152 2-s2.0-18144404640 10.1016/j.amjcard.2005.01.040 (Pubitemid 40616414)
10. Serruys P. W., Umans V., Heyndrickx G. R., Elective PTCA of totally occluded coronary arteries not associated with acute myocardial infarction; short-term and long-term results. European Heart Journal 1985 6 1 2 12 (Pubitemid 15079046)
11. Inoue T., Node K., Molecular basis of restenosis and novel issues of drug-eluting stents. Circulation Journal 2009 73 4 615 621 2-s2.0-65649117678 10.1253/circj.CJ-09-0059
12. Farb A., Weber D. K., Kolodgie F. D., Burke A. P., Virmani R., Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002 105 25 2974 2980 2-s2.0-0037172986 10.1161/01.CIR.0000019071. 72887.BD (Pubitemid 34693829)
13. Uchida Y., Uchida Y., Matsuyama A., Koga A., Kanai M., Sakurai T., Formation of web- and membrane-like structures on the edges of bare-metal coronary stents. Circulation Journal 2010 74 9 1830 1836 2-s2.0-77956125842 10.1253/circj.CJ-10-0093
14. Fuke S., Maekawa K., Kawamoto K., Saito H., Sato T., Hioka T., Ohe T., Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circulation Journal 2007 71 2 220 225 2-s2.0-33846641777 10.1253/circj.71.220 (Pubitemid 46182696)
15. van Beusekom H. M., Whelan D. M., Hofma S. H., Krabbendam S. C., van Hinsbergh V. W., Verdouw P. D., van der Giessen W. J., Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. Journal of the American College of Cardiology 1998 32 4 1109 1117 2-s2.0-0032192119 10.1016/S0735-1097(98)00348-9 (Pubitemid 28459607)
16. Indolfi C., Curcio A., Chiariello M., Simvastatin reduces neointimal thickening after experimental angioplasty. Circulation 2003 107 3 e25 2-s2.0-18144451297
17. Indolfi C., Torella D., Coppola C., Stabile E., Esposito G., Curcio A., Pisani A., Cavuto L., Arcucci O., Cireddu M., Troncone G., Chiariello M., Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture. American Journal of Physiology 2002 283 2 H760 H767 2-s2.0-0036073194 (Pubitemid 34790872)
18. Hamasaki S., hamasksh@m.kufm.kagoshima-u.ac.jp Tei C., Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. Journal of Cardiology 2011 57 3 231 238 10.1016/j.jjcc.2011.02.003
19. Williams K. J., Tabas I., The response-to-retention hypothesis of early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 5 551 562 2-s2.0-0029299438
20. Borissoff J. I., j.ilcheff@maastrichtuniversity.nl Heeneman S., Kilin E., Kaššák P., Oerle R. V., Winckers K., Govers-Riemslag J. W.P., Hamulyák K., Hackeng T. M., Daemen M. J.A.P., Cate H. T., Spronk H. M., Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 2010 122 8 821 830 10.1161/CIRCULATIONAHA.109.907121
21. Rahmani M., Cruz R. P., Granville D. J., McManus B. M., Allograft vasculopathy versus atherosclerosis. Circulation Research 2006 99 8 801 815 2-s2.0-33749681864 10.1161/01.RES.0000246086.93555.f3 (Pubitemid 44556379)
22. Parmar J. H., Aslam M., Standfield N. J., Percutaneous transluminal angioplasty of lower limb arteries causes a systemic inflammatory response. Annals of Vascular Surgery 2009 23 5 569 576 2-s2.0-69849109241 10.1016/j.avsg.2009.02.004
23. Cunningham K. S., Gotlieb A. I., The role of shear stress in the pathogenesis of atherosclerosis. Laboratory Investigation 2005 85 1 9 23 2-s2.0-12344306644 10.1038/labinvest.3700215 (Pubitemid 40128037)
24. Chiu J. J., Chien S., Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiological Reviews 2011 91 1 327 387 10.1152/physrev.00047.2009
25. Mitra A. K., Del Core M. G., Agrawal D. K., Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies. Canadian Journal of Physiology and Pharmacology 2005 83 8-9 701 715 2-s2.0-28944446725 10.1139/y05-080 (Pubitemid 41784009)
26. Cuneo A. A., Autieri M. V., Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury. Current Vascular Pharmacology 2009 7 3 267 276 2-s2.0-69149085564 10.2174/ 157016109788340721
27. Suwanabol P. A., Kent K. C., Liu B., liub@surgery.wisc.edu TGF- β and restenosis revisited: a smad link. Journal of Surgical Research 2011 167 2 287 297 10.1016/j.jss.2010.12.020
28. Piazza G., gpiazza@partners.org Fanikos J., Zayaruzny M., Goldhaber S. Z., Venous thromboembolic events in hospitalised medical patients. Thrombosis and Haemostasis 2009 102 3 505 510 10.1160/TH09-03-0150
29. Pasceri V., Willerson J. T., Yeh E. T., Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000 102 18 2165 2168 2-s2.0-0034739462
30. Venugopal S. K., Devaraj S., Yuhanna I., Shaul P., Jialal I., Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002 106 12 1439 1441 2-s2.0-0037126012 10.1161/01.CIR.0000033116.22237.F9
31. Wang C. H., Li S. H., Weisel R. D., Fedak P. W. M., Dumont A. S., Szmitko P., Li R. K., Mickle D. A. G., Verma S., C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003 107 13 1783 1790 2-s2.0-0037426399 10.1161/01.CIR.0000061916.95736.E5 (Pubitemid 36418360)
32. Torzewski M., Rist C., Mortensen R. F., Zwaka T. P., Bienek M., Waltenberger J., Koenig W., Schmitz G., Hombach V., Torzewski J., C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 9 2094 2099 2-s2.0-0033813079
33. Hansrani M., Gillespie J. I., Stansby G., Homocysteine in myointimal hyperplasia. European Journal of Vascular and Endovascular Surgery 2002 23 1 3 10 2-s2.0-0036134595 10.1053/ejvs.2001.1526 (Pubitemid 41079200)
34. Behrendt D., Ganz P., Endothelial function: from vascular biology to clinical applications. American Journal of Cardiology 2002 90 10 40L 48L 2-s2.0-0037153047 (Pubitemid 35379905)
35. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A. M., Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation. Nature 1999 399 6736 601 605 2-s2.0-0033542476 10.1038/21224 (Pubitemid 29279182)
36. Cooke J. P., Dzau V. J., Nitric oxide synthase: role in the genesis of vascular disease. Annual Review of Medicine 1997 48 489 509 2-s2.0-0031054463 10.1146/annurev.med.48.1.489 (Pubitemid 27101848)
37. Cooke J. P., Singer A. H., Tsao P., Zera P., Rowan R. A., Billingham M. E., Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. Journal of Clinical Investigation 1992 90 3 1168 1172 2-s2.0-0026669343
38. von der Leyen H. E., Gibbons G. H., Morishita R., Lewis N. P., Zhang L., Nakajima M., Kaneda Y., Cooke J. P., Dzau V. J., Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proceedings of the National Academy of Sciences of the United States of America 1995 92 4 1137 1141 2-s2.0-0028798793 10.1073/pnas.92.4.1137
39. Painter T. A., Myointimal hyperplasia: pathogenesis and implications. 1. In vitro characteristics. Artificial Organs 1991 15 1 42 55 2-s2.0-0025966556
40. Dzau V. J., Braun-Dullaeus R. C., Sedding D. G., Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nature Medicine 2002 8 11 1249 1256 2-s2.0-0036851826 10.1038/nm1102-1249 (Pubitemid 35373556)
41. Halayko A. J., Stelmack G. L., The association of caveolae, actin, and the dystrophin-glycoprotein complex: a role in smooth muscle phenotype and function? Canadian Journal of Physiology and Pharmacology 2005 83 10 877 891 2-s2.0-32544448060 10.1139/y05-107 (Pubitemid 43235413)
42. Seow C. Y., Response of arterial smooth muscle to length perturbation. Journal of Applied Physiology 2000 89 5 2065 2072 2-s2.0-0033763133
43. Insel P. A., Patel H. H., Membrane rafts and caveolae in cardiovascular signaling. Current Opinion in Nephrology and Hypertension 2009 18 1 50 56 2-s2.0-58149252098 10.1097/MNH.0b013e3283186f82
44. Thyberg J., Differences in caveolae dynamics in vascular smooth muscle cells of different phenotypes. Laboratory Investigation 2000 80 6 915 929 2-s2.0-0033945385 (Pubitemid 30421808)
45. Moiseeva E. P., Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovascular Research 2001 52 3 372 386 2-s2.0-0035216201 10.1016/S0008-6363(01)00399-6 (Pubitemid 33153100)
46. Schwartz S. M., deBlois D., O'Brien E. R., The intima: soil for atherosclerosis and restenosis. Circulation Research 1995 77 3 445 465 2-s2.0-0029098078
47. Campbell G. R., Campbell J. H., Manderson J. A., Horrigan S., Rennick R. E., Arterial smooth muscle. A multifunctional mesenchymal cell. Archives of Pathology and Laboratory Medicine 1988 112 10 977 986 2-s2.0-0023737362
48. Scott N. A., Cipolla G. D., Ross C. E., Dunn B., Martin F. H., Simonet L., Wilcox J. N., Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996 93 12 2178 2187 2-s2.0-0029934015 (Pubitemid 26187108)
49. Schwartz S. M., Murry C. E., Proliferation and the monoclonal origins of atherosclerotic lesions. Annual Review of Medicine 1998 49 437 460 2-s2.0-0031969967 10.1146/annurev.med.49.1.437 (Pubitemid 28197465)
50. Religa P., Bojakowski K., Maksymowicz M., Bojakowska M., Sirsjo A., Gaciong Z., Olszewski W., Hedin U., Thyberg J., Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries. Transplantation 2002 74 9 1310 1315 2-s2.0-0037112738 (Pubitemid 35402603)
51. Underwood P. A., Mitchell S. M., Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin. Cardiovascular Research 2000 47 4 749 758 2-s2.0-0033843792 10.1016/S0008- 6363(00)00129-2
52. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells. American Journal of Pathology 2002 161 5 1893 1901 2-s2.0-0036841488 (Pubitemid 35265546)
53. Perez J., Torres R. A., Rocic P., Cismowski M. J., Weber D. S., Darley-Usmar V. M., Lucchesi P. A., amela.Lucchesi@nationwidechildrens.org PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation. American Journal of PhysiologyCell Physiology 2011 301 1 C242 C251 10.1152/ajpcell.00315.2010
54. Halka A. T., Turner N. J., Carter A., Ghosh J., Murphy M. O., Kirton J. P., Kielty C. M., Walker M. G., The effects of stretch on vascular smooth muscle cell phenotype in vitro. Cardiovascular Pathology 2008 17 2 98 102 2-s2.0-40149088152 10.1016/j.carpath.2007.03.001 (Pubitemid 351329635)
55. Denes L., Bori Z., Csonka E., Entz L., Nagy Z., Reverse regulation of endothelial cells and myointimal hyperplasia on cell proliferation by a heatshock protein-coinducer after hypoxia. Stroke 2008 39 3 1022 1024 2-s2.0-41249089121 10.1161/STROKEAHA.107.495754 (Pubitemid 351619557)
56. Yutani C., Imakita M., Ishibashi-Ueda H., Tsukamoto Y., Nishida N., Ikeda Y., Coronary atherosclerosis and interventions: pathological sequences and restenosis. Pathology International 1999 49 4 273 290 2-s2.0-0032920792 10.1046/j.1440-1827.1999.00861.x (Pubitemid 29230791)
57. Costa M. A., Simon D. I., Molecular basis of restenosis and drug-eluting stents. Circulation 2005 111 17 2257 2273 2-s2.0-18244409638 10.1161/01.CIR.0000163587.36485.A7 (Pubitemid 40632443)
58. Stary H. C., Blankenhorn D. H., Chandler A. B., Glagov S., Insull W., Richardson M., Rosenfeld M. E., Schaffer S. A., Schwartz C. J., Wagner W. D., Wissler R. W., A definition of the intima of human arteries and of its atherosclerosis-prone regions: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arteriosclerosis and Thrombosis 1992 12 1 120 134 2-s2.0-0026597265
59. Kipshidze N., Dangas G., Tsapenko M., Moses J., Leon M. B., Kutryk M., Serruys P., Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. Journal of the American College of Cardiology 2004 44 4 733 739 2-s2.0-4143131081 10.1016/j.jacc.2004.04.048 (Pubitemid 39099565)
60. Valgimigli M., Malagutti P., van Mieghem C. A., Vaina S., Ligthart J. M., Sianos G., Serruys P. W., Persistence of neointimal growth 12 months after intervention and occurrence of delayed restenosis in patients with left main coronary artery disease treated with drug-eluting stents. Journal of the American College of Cardiology 2006 47 7 1491 1494 2-s2.0-33645401281 10.1016/j.jacc.2006.01.008
61. Hirschberg K., Entz L., Szabó G., Merkely B., Restenosis following endovascular interventions: clinical and experimental studies. Orvosi Hetilap 2009 150 28 1307 1312 2-s2.0-68949172212 10.1556/OH.2009.28639
62. Pearce B. J., McKinsey J. F., Current status of intravascular stents as delivery devices to prevent restenosis. Vascular and Endovascular Surgery 2003 37 4 231 237 2-s2.0-0042266458 (Pubitemid 36928026)
63. Dósa E., Rugonfalvi-Kiss S., fustge@kut.sote.hu Prohászka Z., fustge@kut.sote.hu Szabó A., Karádi I., fustge@kut.sote.hu Selmeci L., Romics L., fustge@kut.sote.hu Füst G., fustge@kut.sote.hu Acsády G., Entz L., Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflammation Research 2004 53 11 631 635 10.1007/s00011-004-1304-y (Pubitemid 40385322)
64. Rugonfalvi-Kiss S., Dósa E., Madsen H. O., Endrész V., Prohászka Z., Laki J., Karádi I., Gönczöl É., Selmeci L., Romics L., Füst G., Entz L., Garred P., garred@post5.tele.dk High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke 2005 36 5 944 948 10.1161/01.STR.0000160752.67422.18 (Pubitemid 40629281)
65. Széplaki G., Varga L., Laki J., Dósa E., Madsen H. O., Prohászka Z., Szabó A., Acsády G., Selmeci L., Garred P., Füst G., fustge@kut.sote.hu Entz L., Elevated complement C3 is associated with early restenosis after eversion carotid endarterectomy. Thrombosis and Haemostasis 2006 96 4 529 534 10.1160/TH06-05-0263 (Pubitemid 44560690)
66. Szabó A., Laki J., Madsen H. O., Dósa E., Prohászka Z., Rugonfalvi-Kiss S., Kókai M., Acsádi G., Karádi I., Entz L., Selmeci L., Romics L., Füst G., Garred P., garred@post5.tele.dk Cervenak L., Early rise in serum VEGF and PDGF Levels predisposes patients with a normal MBL2 genotype to restenosis after eversion endarterectomy. Stroke 2007 38 8 2247 2253 10.1161/STROKEAHA.106.475954 (Pubitemid 47457563)
67. Széplaki G., Varga L., Laki J., Dósa E., Rugonfalvi-Kiss S., Madsen H. O., Prohászka Z., Kocsis A., Gál P., Szabó A., Acsády G., Karádi I., Selmeci L., Garred P., Füst G., fustge@kut.sote.hu Entz L., Low C1-inhibitor levels predict early restenosis after eversion carotid endarterectomy. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 12 2756 2762 10.1161/ATVBAHA.107.146860 (Pubitemid 350158933)
68. Ding R. Q., Tsao J., Chai H., Mochly-Rosen D., Zhou W., weizhou@stanford.edu Therapeutic potential for protein kinase C inhibitor in vascular restenosis. Journal of Cardiovascular Pharmacology and Therapeutics 2011 16 2 160 167 10.1177/1074248410382106
69. Geiringer E., Intimal vascularization and atherosclerosis. The Journal of pathology and bacteriology 1951 63 2 201 211 2-s2.0-0000582946
70. Post S., Peeters W., Busser E., Lamers D., Sluijter J. P. G., Goumans M. J., De Weger R. A., Moll F. L., Doevendans P. A., Pasterkamp G., Vink A., Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. Journal of Vascular Research 2008 45 3 244 250 2-s2.0-42149086469 10.1159/000112939 (Pubitemid 351543148)
71. Freedman S. B., Isner J. M., Therapeutic angiogenesis for coronary artery disease. Annals of Internal Medicine 2002 136 1 54 71 2-s2.0-0036137469 (Pubitemid 34038697)
72. Khurana R., Martin J. F., Zachary I., Gene therapy for cardiovascular disease: a case for cautious optimism. Hypertension 2001 38 5 1210 1216 2-s2.0-0035724762 (Pubitemid 34252833)
73. Edelberg J. M., Tang L., Hattori K., Lyden D., Rafii S., Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circulation research 2002 90 10 E89 E93 2-s2.0-18244421981
74. + cells identifies a population of functional endothelial precursors. Blood 2000 95 3 952 958 2-s2.0-12944253116 (Pubitemid 30062717)
75. Orlandi A., Bennett M., Progenitor cell-derived smooth muscle cells in vascular disease. Biochemical Pharmacology 2010 79 12 1706 1713 2-s2.0-77951297553 10.1016/j.bcp.2010.01.027
76. Nánási P. P., Jednákovits A., Multilateral in vivo and in vitro protective effects of the novel heat shock protein coinducer, bimoclomol: results of preclinical studies. Cardiovascular Drug Reviews 2001 19 2 133 151 2-s2.0-0034894697 (Pubitemid 32703322)
77. Vígh L., Literáti P. N., Horváth I., Török Z., Balogh G., Glatz A., Kovács E., Boros I., Ferdinándy P., Farkas B., Jaszlits L., Jednákovits A., Korányi L., Maresca B., Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein- inducing activity and cytoprotective effects. Nature Medicine 1997 3 10 1150 1154 2-s2.0-20244367890 10.1038/nm1097-1150 (Pubitemid 27444460)
78. Dénes L., Jednákovits A., Hargitai J., Pénzes Z., Balla A., Tálosi L., Krajcsi P., Csermely P., Pharmacologically activated migration of aortic endothelial cells is mediated through p38 SAPK. British Journal of Pharmacology 2002 136 4 597 603 2-s2.0-0035984947 (Pubitemid 34717704)
79. Hirschberg K., Radovits T., Loganathan S., Entz L., Beller C. J., Gross M. L., Sandner P., Karck M., Szabó G., Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy. Journal of Thoracic and Cardiovascular Surgery 2009 137 6 1508 1514 2-s2.0-67349190578 10.1016/j.jtcvs.2008.10.016
80. Liistro F., Stankovic G., Di Mario C., Takagi T., Chieffo A., Moshiri S., Montorfano M., Carlino M., Briguori C., Pagnotta P., Albiero R., Corvaja N., Colombo A., First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 2002 105 16 1883 1886 2-s2.0-0037161356 10.1161/01.CIR.0000016042.69606.61 (Pubitemid 34437612)
81. Vorpahl M., Yazdani S. K., Nakano M., Ladich E., Kolodgie F. D., Finn A. V., Virmani R., rvirmani@cvpath.org Pathobiology of stent thrombosis after drug-eluting stent implantation. Current Pharmaceutical Design 2010 16 36 4064 4071 10.2174/138161210794454879
82. Walter D. H., Cejna M., Diaz-Sandoval L., Willis S., Kirkwood L., Stratford P. W., Tietz A. B., Kirchmair R., Silver M., Curry C., Wecker A., Yoon Y. S., Heidenreich R., Hanley A., Kearney M., Tio F. O., Kuenzler P., Isner J. M., Losordo D. W., Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004 110 1 36 45 2-s2.0-3042828271 10.1161/01.CIR.0000133324.38115.0A (Pubitemid 38885702)
83. Vaishnav P., Demain A. L., Unexpected applications of secondary metabolites. Biotechnology Advances 2011 29 223 229 2-s2.0-78650322789 10.1016/j.biotechadv.2010.11.006
84. Nikol S., nikol@uni-muenster.de Gene therapy of cardiovascular disease. Current Opinion in Molecular Therapeutics 2008 10 5 479 492
85. Rissanen T. T., Ylä-Herttuala S., Current status of cardiovascular gene therapy. Molecular Therapy 2007 15 7 1233 1247 2-s2.0-34250772826 10.1038/sj.mt.6300175 (Pubitemid 46965318)
86. Sharif F., Hynes S. O., McMahon J., Cooney R., Conroy S., Dockery P., Duffy G., Daly K., Crowley J., Bartlett J. S., O'Brien T., Gene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo. Human Gene Therapy 2006 17 7 741 750 2-s2.0-33746218887 10.1089/hum.2006.17.741 (Pubitemid 44100719)
87. Gaffney M. M., Hynes S. O., Barry F., O'Brien T., Cardiovascular gene therapy: current status and therapeutic potential. British Journal of Pharmacology 2007 152 2 175 188 2-s2.0-34948856860 10.1038/sj.bjp.0707315 (Pubitemid 47517600)
88. von der Leyen H. E., vdleyen@clinical-trial-center.de Mügge A., Hanefeld C., Hamm C. W., Rau M., Rupprecht H. J., Zeiher A. M., Fichtlscherer S., A Prospective, single-blind, multicenter, dose escalation study of intracoronary iNOS Lipoplex (CAR-MP583) gene therapy for the prevention of restenosis in patients with de novo or restenotic coronary artery lesion (regent i extension). Human Gene Therapy 2011 22 8 951 958 10.1089/hum.2010.161